TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03264040

Biomarker for Mannosidosis Disease (BioMannosidosis)

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.
“Transition to BioMetabol”

The sponsor’s own words in the registry.

Life of this trial

20172018201920202021202220232024Registered2017-08-24Planned start2018-08-20 (planned)Withdrawn (as of)2023-02-13

Vital statistics

Status
Withdrawn
Sponsor
CENTOGENE GmbH Rostock
Sponsor type
Industry
Conditions
Alpha-Mannosidase B Deficiency; Lysosomal Alpha B Mannosidosis; Alpha-Mannosidase Deficiency
Participants
0
Sites
3
Countries
Germany, India, Sri Lanka

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.